Role of H3K4 demethylases in complex neurodevelopmental diseases

Epigenomics

Volumn 2, Issue 3, 2010, Pages 407-418

  Wynder, Christopher ^a   Stalker, Leanne ^a   Doughty, Martin L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

autism; brain development; gene regulation; histone demethylation

Indexed keywords

DNA; HISTONE; HISTONE H3; LYSINE; RNA; RNA POLYMERASE;

AUTISM; BRAIN DEVELOPMENT; DEMETHYLATION; DEVELOPMENTAL DISORDER; DNA PROTEIN COMPLEX; ENZYME ACTIVITY; ENZYME STRUCTURE; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENOMICS; HUMAN; METHYLATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RETT SYNDROME; REVIEW; TRANSCRIPTION REGULATION;

AUTISTIC DISORDER; DNA-DIRECTED RNA POLYMERASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE DEMETHYLASES; HISTONES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYSINE; NERVOUS SYSTEM DISEASES; NUCLEAR PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; REPRESSOR PROTEINS; RETT SYNDROME;

EID: 77954134377     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.12     Document Type: Review

References (112)

1. Levenson JM, Sweatt JD: Epigenetic mechanisms in memory formation. Nat. Rev. Neurosci. 6(2), 108-118 (2005).
2. Shilatifard A: Chromatin modifcations by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem. 75, 243-269 (2006).
3. Li B, Carey M, Workman JL: The role of chromatin during transcription. Cell 128(4), 707-719 (2007).
4. Vermeulen M, Mulder K W, Denissov S et al.: Selective anchoring of TFIID to nucleosomes by trimethylation of histone h3 lysine 4. Cell 131(1), 58-69 (2007).
5. Holstege FC, Jennings EG, Wyrick JJ et al.: Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95(5), 717-728 (1998).
6. Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells.[see comment]. Cell 125(2), 315-326 (2006).
7. Zhao XD, Han X, Chew JL et al.: Whole-genome mapping of histone H3 lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1(3), 286-298 (2007).
8. Wang J, Hevi S, Kurash JK et al.: The lysine demethylase lsd1 (kdm1) is required for maintenance of global DNA methylation. Nat. Genet. 41(1), 125-129 (2009).
9. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP: Large histone h3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat. Genet. 41(2), 246-250 (2009).
10. Jorgensen HF, Giadrossi S, Casanova M et al.: Stem cells primed for action: polycomb repressive complexes restrain the expression of lineage-specifc regulators in embryonic stem cells. Cell Cycle 5(13), 1411-1414 (2006).
11. Lee MG, Villa R, Trojer P et al.: Demethylation of H3K27 regulates polycomb recruitment and h2a ubiquitination. Science 318(5849), 447-450 (2007).
12. Burgold T, Spreafco F, De Santa F et al.: The histone H3 lysine 27-specifc demethylase jmjd3 is required for neural commitment. PLoS One 3(8), E3034 (2008).
13. Milne TA, Dou Y, Martin ME, Brock HW, Roeder RG, Hess JL: Mll associates specifcally with a subset of transcriptionally active target genes. Proc. Natl Acad. Sci. USA 102(41), 14765-14770 (2005).
14. Wang P, Lin C, Smith ER et al.: Global analysis of H3K4 methylation defines mll family member targets and points to a role for mll1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell Biol. 29(22), 6074-6085 (2009).
15. Schneider J, Wood A, Lee JS et al.: Molecular regulation of histone H3 trimethylation by compass and the regulation of gene expression. Mol. Cell 19(6), 849-856 (2005).
16. Hakimi MA, Dong Y, Lane WS, Speicher DW, Shiekhattar R: A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J. Biol. Chem. 278(9), 7234-7239 (2003).
17. Madsen B, Spencer-Dene B, Poulsom R et al.: Characterisation and developmental expression of mouse plu-1, a homologue of a human nuclear protein (plu-1) which is specifcally up-regulated in breast cancer. Gene Expr. Patterns 2(3-4), 275-282 (2002). (Pubitemid 36358186)
18. Iwase S, Lan F, Bayliss P et al.: The x-linked mental retardation gene smcx/jarid1c defines a family of histone H3 lysine 4 demethylases. Cell 128(6), 1077-1088 (2007).
19. Xu J, Deng X, Disteche CM: Sex-specifc expression of the X-linked histone demethylase gene jarid1c in brain. PLoS One 3(7), E2553 (2008).
20. Kornberg RD, Lorch Y: Twenty-fve years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98(3), 285-294 (1999).
21. Sims RJ 3rd, Nishioka K, Reinberg D: Histone lysine methylation: a signature for chromatin function. Trends Genet. 19(11), 629-639 (2003).
22. Volkel P, Angrand PO: The control of histone lysine methylation in epigenetic regulation. Biochimie 89(1), 1-20 (2007).
23. Kouzarides T: Chromatin modifcations and their function. Cell 128(4), 693-705 (2007).
24. Cloos PA, Christensen J, Agger K, Helin K: Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22(9), 1115-1140 (2008).
25. Shi Y, Whetstine JR: Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25(1), 1-14 (2007).
26. Szutorisz H, Canzonetta C, Georgiou A, Chow CM, Tora L, Dillon N: Formation of an active tissue-specifc chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol. Cell Biol. 25(5), 1804-1820 (2005)
27. Sims RJ 3rd, Millhouse S, Chen CF et al.: Recognition of trimethylated histone h3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28(4), 665-676 (2007).
28. Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
29. Margueron R, Trojer P, Reinberg D: The key to development: interpreting the histone code? Curr. Opin. Genet. Dev. 15(2), 163-176 (2005).
30. Robertson AG, Bilenky M, Tam A et al.: Genome-wide relationship between histone h3 lysine 4 mono-and tri-methylation and transcription factor binding. Genome Res. 18(12), 1906-1917 (2008).
31. Santos-Rosa H, Schneider R, Bannister AJ et al.: Active genes are tri-methylated at K4 of histone H3. Nature 419(6905), 407-411 (2002).
32. Campos EI, Reinberg D: Histones: annotating chromatin. Annu. Rev. Genet. 43, 559-599 (2009).
33. Pinskaya M, Morillon A: Histone h3 lysine 4 di-methylation: a novel mark for transcriptional fdelity? Epigenetics 4(5), 302-306 (2009).
34. Mikkelsen TS, Ku M, Jaffe DB et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007).
35. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130(1), 77-88 (2007).
36. Doyle JP, Dougherty JD, Heiman M et al.: Application of a translational profling approach for the comparative analysis of CNS cell types. Cell 135(4), 749-762 (2008).
37. Heiman M, Schaefer A, Gong S et al.: A translational profling approach for the molecular characterization of CNS cell types. Cell 135(4), 738-748 (2008).
38. Shi Y, Lan F, Matson C et al.: Histone demethylation mediated by the nuclear amine oxidase homolog lsd1. Cell 119(7), 941-953 (2004).
39. Wang J, Scully K, Zhu X et al.: Opposing lsd1 complexes function in developmental gene activation and repression programmes. Nature 446(7138), 882-887 (2007).
40. Katoh-Semba R, Wakako R, Komori T et al.: Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int. J. Dev. Neurosci. 25(6), 367-372 (2007).
41. Dyck BA, Skoblenick KJ, Castellano JM, Ki K, Thomas N, Mishra RK: Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. Synapse (New York, NY) 63(8), 662-672 (2009).
42. Sondhi S, Castellano JM, Chong VZ et al.: CDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics J. 6(2), 131-140 (2006).
43. Ciccone DN, Su H, Hevi S et al.: Kdm1b is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461(7262), 415-418 (2009).
44. Lalande M, Calciano MA: Molecular epigenetics of angelman syndrome. Cell Mol. Life Sci. 64(7-8), 947-960 (2007).
45. Lee MG, Wynder C, Schmidt DM, Mccafferty DG, Shiekhattar R: Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 13(6), 563-567 (2006).
46. Klose RJ, Kallin EM, Zhang Y: Jmjc-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7(9), 715-727 (2006).
47. Seward DJ, Cubberley G, Kim S et al.: Demethylation of trimethylated histone H3 lys4 in vivo by jarid1 JmjC proteins. Nat. Struct. Mol. Biol. 14(3), 240-242 (2007).
48. Tsai MH, Cook JA, Chandramouli GV et al.: Gene expression profling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 67(8), 3845-3852 (2007).
49. Trewick SC, Mclaughlin PJ, Allshire RC: Methylation: lost in hydroxylation? EMBO Rep. 6(4), 315-320 (2005).
50. Tsukada Y, Fang J, Erdjument-Bromage H et al.: Histone demethylation by a family of JmjC domain-containing proteins. Nature 439(7078), 811-816 (2006).
51. Yamane K, Tateishi K, Klose RJ et al.: Plu-1 is an h3k4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25(6), 801-812 (2007).
52. Secombe J, Eisenman RN: The function and regulation of the jarid1 family of histone h3 lysine 4 demethylases: the myc connection. Cell Cycle 6(11), 1324-1328 (2007).
53. Klose RJ, Yan Q, Tothova Z et al.: The retinoblastoma binding protein rbp2 is an h3k4 demethylase. Cell 128(5), 889-900 (2007).
54. Kortschak RD, Tucker PW, Saint R: Arid proteins come in from the desert. Trends Biochem. Sci. 25(6), 294-299 (2000).
55. Wysocka J, Swigut T, Xiao H et al.: A phd finger of nurf couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098), 86-90 (2006).
56. Mellor J: It takes a phd to read the histone code. Cell 126(1), 22-24 (2006).
57. Lu PJ, Sundquist K, Baeckstrom D et al.: A novel gene (plu-1) containing highly conserved putative DNA/chromatin binding motifs is specifcally up-regulated in breast cancer. J. Biol. Chem. 274(22), 15633-15645 (1999).
58. Barrett A, Madsen B, Copier J et al.: Plu-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int. J. Cancer 101(6), 581-588 (2002).
59. Barrett A, Santangelo S, Tan K et al.: Breast cancer associated transcriptional repressor plu-1/jarid1b interacts directly with histone deacetylases. Int. J. Cancer 121(2), 265-275 (2007).
60. Dey BK, Stalker L, Schnerch A, Bhatia M, Taylor-Papidimtriou J, Wynder C: The histone demethylase kdm5b/jarid1b plays a role in cell fate decisions by blocking terminal differentiation. Mol. Cell Biol. 28(17), 5312-5327 (2008).
61. Tan K, Shaw AL, Madsen B, Jensen K, Taylor-Papadimitriou J, Freemont PS: Human plu-1 has transcriptional repression properties and interacts with the developmental transcription factors bf-1 and pax9. J. Biol. Chem. 278(23), 20507-20513 (2003).
62. Ariani F, Hayek G, Rondinella D et al.: Foxg1 is responsible for the congenital variant of rett syndrome. Am. J. Hum. Genet. 83(1), 89-93 (2008).
63. Mencarelli M, Spanhol-Rosseto A, Artuso R et al.: Novel foxg1 mutations associated with the congenital variant of rett syndrome. J. Med. Genet. 47(1), 49-53 (2009).
64. Papa FT, Mencarelli MA, Caselli R et al.: A 3 mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and rett-like features. Am. J. Med. Genet. 146A(15), 1994-1998 (2008).
65. Shoichet SA, Kunde SA, Viertel P et al.: Haploinsuffciency of novel foxg1b variants in a patient with severe mental retardation, brain malformations and microcephaly. Hum. Genet. 117(6), 536-544 (2005).
66. Wu J, Ellison J, Salido E, Yen P, Mohandas T, Shapiro LJ: Isolation and characterization of xe169, a novel human gene that escapes X-inactivation. Hum. Mol. Genet. 3(1), 153-160 (1994). (Pubitemid 24038158)
67. Wu J, Salido EC, Yen PH et al.: The murine xe169 gene escapes X-inactivation like its human homologue. Nat. Genet. 7(4), 491-496 (1994).
68. Kramer JM, van Bokhoven H: Genetic and epigenetic defects in mental retardation. Int. J. Biochem. Cell Biol. 41(1), 96-107 (2009).
69. Ballas N, Mandel G: The many faces of rest oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15(5), 500-506 (2005).
70. Tahiliani M, Mei P, Fang R et al.: The histone H3K4 demethylase smcx links rest target genes to x-linked mental retardation. Nature 447(7144), 601-605 (2007).
71. Jensen LR, Amende M, Gurok U et al.: Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76(2), 227-236 (2005).
72. Tzschach A, Lenzner S, Moser B et al.: Novel JARID1C/SMCX mutations in patients with x-linked mental retardation. Hum. Mutat. 27(4), 389 (2006).
73. Santos C, Rodriguez-Revenga L, Madrigal I, Badenas C, Pineda M, Mila M: A novel mutation in jarid1c gene associated with mental retardation. Eur. J. Hum. Genet. 14(5), 583-586 (2006).
74. Adegbola A, Gao H, Sommer S, Browning M: A novel mutation in jarid1c/smcx in a patient with autism spectrum disorder (asd). Am. J. Med. Genet. A 146A(4), 505-511 (2008).
75. Wang W, Meadows LR, Den Haan JM et al.: Human H-Y: a male-specifc histocompatibility antigen derived from the smcy protein. Science 269(5230), 1588-1590 (1995).
76. Scott DM, Ehrmann IE, Ellis PS et al.: Identifcation of a mouse male-specifc transplantation antigen, H-Y. Nature 376(6542), 695-698 (1995).
77. Lee MG, Norman J, Shilatifard A, Shiekhattar R: Physical and functional association of a trimethyl H3K4 demethylase and ring6a/mblr, a polycomb-like protein. Cell 128(5), 877-887 (2007).
78. Christensen J, Agger K, Cloos PA et al.: Rbp2 belongs to a family of demethylases, specifc for tri-and dimethylated lysine 4 on histone 3. Cell 128(6), 1063-1076 (2007).
79. Akasaka T, Takahashi N, Suzuki M, Koseki H, Bodmer R, Koga H: Mblr, a new ring finger protein resembling mammalian polycomb gene products, is regulated by cell cycle-dependent phosphorylation. Genes Cells 7(8), 835-850 (2002).
80. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y: A complex with chromatin modifers that occupies e2f-and myc-responsive genes in G0 cells. Science 296(5570), 1132-1136 (2002).
81. Benayed R, Gharani N, Rossman I et al.: Support for the homeobox transcription factor gene engrailed 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet. 77(5), 851-868 (2005).
82. Titomanlio L, Pierri NB, Romano A et al.: Cerebellar vermis aplasia: patient report and exclusion of the candidate genes EN2 and ZIC1. Am. J. Med. Genet. 136(2), 198-200 (2005).
83. Akbarian S, Huang HS: Epigenetic regulation in human brain-focus on histone lysine methylation. Biol. Psychiatry 65(3), 198-203 (2009).
84. Hakimi MA, Bochar DA, Chenoweth J, Lane WS, Mandel G, Shiekhattar R: A CORE-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specifc genes. Proc. Natl Acad. Sci. USA 99(11), 7420-7425 (2002).
85. Lee MG, Wynder C, Bochar DA, Hakimi MA, Cooch N, Shiekhattar R: Functional interplay between histone demethylase and deacetylase enzymes. Mol. Cell. Biol. 26(17), 6395-6402 (2006).
86. Ooi SK, Qiu C, Bernstein E et al.: Dnmt3l connects unmethylated lysine 4 of histone h3 to de novo methylation of DNA. Nature 448(7154), 714-717 (2007).
87. Ng HH, Bird A: DNA methylation and chromatin modifcation. Curr. Opin. Genet. Dev. 9(2), 158-163 (1999).
88. Moretti P, Zoghbi HY: Mecp2 dysfunction in rett syndrome and related disorders. Curr. Opin. Genet. Dev. 16(3), 276-281 (2006).
89. Urdinguio RG, Lopez-Serra L, Lopez-Nieva P et al.: MECP2-null mice provide new neuronal targets for rett syndrome. PLoS One 3(11), E3669 (2008).
90. Meaney MJ, Szyf M, Seckl JR: Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol. Med. 13(7), 269-277 (2007).
91. Cameron NM, Shahrokh D, Del Corpo A et al.: Epigenetic programming of phenotypic variations in reproductive strategies in the rat through maternal care. J. Neuroendocrinol. 20(6), 795-801 (2008).
92. Weaver IC, D'alessio AC, Brown SE et al.: The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J. Neurosci 27(7), 1756-1768 (2007).
93. Champagne FA, Weaver IC, Diorio J, Dymov S, Szyf M, Meaney MJ: Maternal care associated with methylation of the estrogen receptor-a1b promoter and estrogen receptor-a expression in the medial preoptic area of female offspring. Endocrinolog y 147(6), 2909-2915 (2006).
94. Mcgowan PO, Sasaki A, D'alessio AC et al.: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12(3), 342-348 (2009).
95. Fish EW, Shahrokh D, Bagot R et al.: Epigenetic programming of stress responses through variations in maternal care. Ann. NY Acad. Sci. 1036, 167-180 (2004).
96. Szyf M, Mcgowan P, Meaney MJ: The social environment and the epigenome. Environ. Mol. Mutagen. 49(1), 46-60 (2008).
97. Wynder C, Hakimi MA, Epstein JA, Shilatifard A, Shiekhattar R: Recruitment of MLL by HMG-domain protein ibraf promotes neural differentiation. Nat. Cell Biol. 7(11), 1113-1117 (2005).
98. Carling T, Kim KC, Yang XH, Gu J, Zhang XK, Huang S: A histone methyltransferase is required for maximal response to female sex hormones. Mol. Cell Biol. 24(16), 7032-7042 (2004).
99. Hu Q, Kwon YS, Nunez E et al.: Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl Acad. Sci. USA 105(49), 19199-19204 (2008).
100. Ooi L, Wood IC: Regulation of gene expression in the nervous system. Biochem. J. 414(3), 327-341 (2008).
101. Abel T, Zukin RS: Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8(1), 57-64 (2008).
102. Seong IS, Woda JM, Song JJ et al.: Huntingtin facilitates polycomb repressive complex 2. Hum. Mol. Genet. 19(4), 573-583 (2009).
103. Urdinguio RG, Pino I, Ropero S, Fraga MF, Esteller M: Histone H3 and H4 modifcation profles in a rett syndrome mouse model. Epigenetics 2(1), 11-14 (2007).
104. Shahbazian M, Young J, Yuva-Paylor L et al.: Mice with truncated MECP2 recapitulate many rett syndrome features and display hyperacetylation of histone h3. Neuron 35(2), 243-254 (2002).
105. Samaco RC, Hogart A, Lasalle JM: Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 defciency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14(4), 483-492 (2005).
106. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G: Rest and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121(4), 645-657 (2005).
107. Courchesne E, Pierce K, Schumann CM et al.: Mapping early brain development in autism. Neuron 56(2), 399-413 (2007).
108. Freitag CM, Luders E, Hulst HE et al.: Total brain volume and corpus callosum size in medication-naive adolescents and young adults with autism spectrum disorder. Biol. Psychiatry 66(4), 316-319 (2009).
109. Lombardo M V, Chakrabarti B, Baron-Cohen S: The amygdala in autism: not adapting to faces? Am. J. Psychiatry 166(4), 395-397 (2009).
110. Bahi-Buisson N, Nectoux J, Girard B et al.: Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics 11(2), 241-249 (2009).
111. Lee MG, Wynder C, Schmidt DM, Mccafferty DG, Shiekhattar R: Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 13(6), 563-567 (2006).
112. Huang Y, Greene E, Murray Stewart T et al.: Inhibition of lysine-specifc demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl Acad. Sci. USA 104(19), 8023-8028 (2007).